These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9377676)

  • 1. [Activity of cathepsin D in some neoplasms of the gastrointestinal tract].
    Kiluk M; Skrzydlewski Z; Kiluk A; Woroniecki A; Rucińska M; Kozłowski L
    Pol Merkur Lekarski; 1997 May; 2(11):307-8. PubMed ID: 9377676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cathepsin D and carcino-embryonic antigen in serum, urine and tissues of colon adenocarcinoma patients.
    Szajda SD; Snarska J; Jankowska A; Roszkowska-Jakimiec W; Puchalski Z; Zwierz K
    Hepatogastroenterology; 2008; 55(82-83):388-93. PubMed ID: 18613372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cancer procoagulant and cathepsin D activity in blood serum in patients with bladder cancer].
    Szajda SD; Darewicz B; Kudelski J; Chlabicz M; Domel T; Chabielska E; Skrzydlewski Z
    Pol Merkur Lekarski; 2005 Jun; 18(108):651-3. PubMed ID: 16124376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin D activity in colorectal cancer.
    Chabowski A; Skrzydlewska E; Sulkowska M; Famulski W; Zalewski B; Gnojnicki I; Kisielewski W
    Rocz Akad Med Bialymst; 2001; 46():38-46. PubMed ID: 11780577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of cathepsin B and D in colorectal cancer: relationships with tumour budding.
    Guzińska-Ustymowicz K; Zalewski B; Kasacka I; Piotrowski Z; Skrzydlewska E
    Anticancer Res; 2004; 24(5A):2847-51. PubMed ID: 15517887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cathepsin D activity in gastric cancer].
    Kantsaliev AL; Kozyreva EA; Kushlinskiĭ NE; Rottenberg VI; Klimenkov AA; Vasil'ev AV
    Vopr Onkol; 1994; 40(1-3):40-6. PubMed ID: 7701792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostic significance of cancer procoagulant activity in colorectal cancer].
    Kozuszko B; Skrzydlewski Z; Famulski W
    Pol Merkur Lekarski; 2000 Mar; 8(45):127-8. PubMed ID: 10870414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Significance of cathepsin B and D in physiologic and pathologic processes].
    Olszewska D; Drewa T; Makarewicz R; Drewa J; Woźniak A; Maciak R
    Pol Merkur Lekarski; 2001 Jan; 10(55):65-70. PubMed ID: 11320558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Proteases and prostatic disease: cytosolic cathepsin D].
    Gómez Díaz ME; Ruibal-Morell A; Abascal García R
    Arch Esp Urol; 2001 Mar; 54(2):101-7. PubMed ID: 11341113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical value of cathepsin-D and TNF-alpha in bladder cancer patients.
    Salman T; el-Ahmady O; el-Shafee M; Omar S; Salman I
    Anticancer Res; 1997; 17(4B):3087-90. PubMed ID: 9329608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of proliferation and chemosensitivity by procathepsin D and its peptides in ovarian cancer.
    Bazzett LB; Watkins CS; Gercel-Taylor C; Taylor DD
    Gynecol Oncol; 1999 Aug; 74(2):181-7. PubMed ID: 10419729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. May cathepsin D immunoreactivity be used as a prognostic factor in endometrial carcinomas? A comparative immunohistochemical study.
    Saygili U; Koyuncuoglu M; Altunyurt S; Guclu S; Uslu T; Erten O
    Gynecol Oncol; 2001 Oct; 83(1):20-4. PubMed ID: 11585409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution of cathepsin D granules in normal and pathologic conditions in human prostate.
    Islam AH; Kato H; Nishizawa O; Hayama M
    Hinyokika Kiyo; 2002 Nov; 48(11):647-52. PubMed ID: 12512135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of cathepsin D in breast cancer.
    Stehle G; Wunder A; Hartung G; Sinn H; Heene DL
    Br J Cancer; 1999 Dec; 81(8):1427-8. PubMed ID: 10604744
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of cathepsin D in breast cancer and its clinical and histopathological correlations].
    Ramírez-Ortega MC; Frías-Mendívil M; Delgado-Chávez R; Meneses-García A; Carrillo-Hernández JF; Ramírez-Ugalde MT; Zeichner-Gancz I
    Rev Invest Clin; 1997; 49(5):361-8. PubMed ID: 9527695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of cytosolyc cathepsin D content in resectable gastric cancer.
    Manuel Del Casar J; Vizoso FJ; Abdel-Laa O; Sanz L; Martín A; Daniela Corte M; Bongera M; García Muñiz JL; Fueyo A
    J Surg Oncol; 2004 Apr; 86(1):16-21. PubMed ID: 15048675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum activity of chitotriosidase, lysozyme and cathepsin H in patients with lung cancer and patients with inflammatory exudate (preliminary report)].
    Gołab K; Passowicz-Muszyńska E; Jankowska R; Warwas M
    Pol Merkur Lekarski; 2009 Mar; 26(153):194-7. PubMed ID: 19388531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cathepsin D activity in human ovarian carcinoma].
    Reich W; Wagner F; Hofmann KD; Marzotko F; Schmeisser G
    Zentralbl Gynakol; 1984; 106(3):196-200. PubMed ID: 6702349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin D in ovarian cancer: prognostic value and correlation with p53 expression and microvessel density.
    Lösch A; Schindl M; Kohlberger P; Lahodny J; Breitenecker G; Horvat R; Birner P
    Gynecol Oncol; 2004 Feb; 92(2):545-52. PubMed ID: 14766246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin D expression in renal cell cancer-clinical implications.
    Merseburger AS; Hennenlotter J; Simon P; Ohneseit PA; Kuehs U; Kruck S; Koch E; Vogel U; Stenzl A; Kuczyk MA
    Eur Urol; 2005 Sep; 48(3):519-26. PubMed ID: 16115525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.